StockData
Healthcare Triangle, Inc. logo

Healthcare Triangle, Inc. (HCTI) stock

HCTINasdaqServices-Computer Integrated Systems DesignFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$3.38+0.05 (+1.50%)

Close on Nov 17, 2026Market cap $6.85MP/E –Yield –

Healthcare Triangle r&d expenses

Research and development expenses are spending on new products and technology.

Healthcare Triangle's R&D Expenses for the twelve months ending Jun 30, 2026 was $474.00K. For fiscal 2025 it was $536.00K, up 24.9% from the year before. The highest annual figure on record is $8.14M in fiscal 2022.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$536.00K+24.9%
FY2024Dec 31, 2024$429.00K-46.3%
FY2023Dec 31, 2023$799.00K-90.2%
FY2022Dec 31, 2022$8.14M+54.8%
FY2021Dec 31, 2021$5.26M+201.6%
FY2020Dec 31, 2020$1.74M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$51.00K-7.3%
Q1 FY2026Mar 31, 2026$85.00K-41.0%
Q4 FY2025Dec 31, 2025$279.00K+59.4%
Q3 FY2025Sep 30, 2025$59.00K-71.5%
Q2 FY2025Jun 30, 2025$55.00K-56.7%
Q1 FY2025Mar 31, 2025$144.00K+38.5%
Q3 FY2024Sep 30, 2024$175.00K+224.1%
Q2 FY2024Jun 30, 2024$207.00K+102.9%
Q1 FY2024Mar 31, 2024$127.00K-76.4%
Q4 FY2023Dec 31, 2023$104.00K-97.9%
Q3 FY2023Sep 30, 2023$54.00K-96.3%
Q2 FY2023Jun 30, 2023$102.00K-84.2%
Q1 FY2023Mar 31, 2023$539.00K-49.4%
Q4 FY2022Dec 31, 2022$4.96M+234.3%
Q3 FY2022Sep 30, 2022$1.47M-33.3%
Q2 FY2022Jun 30, 2022$646.00K-20.5%
Q1 FY2022Mar 31, 2022$1.07M+40.8%
Q4 FY2021Dec 31, 2021$1.48M+441.5%
Q3 FY2021Sep 30, 2021$2.20M+300.6%
Q2 FY2021Jun 30, 2021$813.00K–
Q1 FY2021Mar 31, 2021$757.00K–
Q4 FY2020Dec 31, 2020$273.66K–
Q3 FY2020Sep 30, 2020$550.17K–

More Healthcare Triangle figures

See a number that looks wrong?